NCT04475224 - Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions

Acute Spinal Cord Injury

Interventions

DRUG

KP-100IT

Intrathecal injection of 0.6 mg HGF starting at 72 hours since the injury and repeating weekly 5 times

Trial Locations (5)

RECRUITING

Spinal Injuries Center, Iizuka

RECRUITING

Hokkaido Spinal Cord Injury Center, Bibai

RECRUITING

Japanese Red Cross Kobe Hospital, Kobe

RECRUITING

Aijinkai Rehabilitation Hospital, Takatsuki

RECRUITING

Murayama Medical Center, Musashimurayama